** Shares of industrial products maker Fortive FTV.N down 1% at $48 in premarket trading
** Barclays downgrades rating to "equal-weight" from "overweight", also cuts PT to $54 from $58
** The new PT still represents a 10.8% upside to the stock's last close
** Barclays says co's second-half outlook seems tough to achieve, with slow growth and limited capital deployment
** Notes that without renewed momentum in Fortive's Advanced Healthcare Solutions segment, investor enthusiasm may remain muted
** Eight of 20 brokerages rate the stock "buy" or higher, twelve "hold"; their median PT is $57 - data compiled by LSEG
** As of last close, stock had fallen 13.8% YTD